Horizon has been ranked as one of the fastest growing biotechnology companies in Europe with a customer base exceeding 1,000 organisations including major pharmaceutical, biotech and diagnostic companies as well as leading academic research centres. Recent growth has been particularly rapid. Since the start of 2014 the company has transitioned from a private UK life science business employing 74 staff on a single 18,000 sq. ft. site in Cambridge to a publicly-listed international life science group employing 183 staff across 84,000 sq. ft. of facilities located in Cambridge (UK), Boston (USA), St Louis (USA) and Boyertown (USA), and since the period end we have also added a facility in Vienna (Austria).
Horizon was founded by Dr Chris Torrance and Professor Alberto Bardelli and builds upon a 20 year heritage in oncology research, translational medicine and genome-editing.